AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28341129
Drug: Hand washing
RxNorm normalized name: ALCOHOL 350 mL in 500 mL EXTRACORPOREAL GEL [75% alcohol free hand washing gel]
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand washing with soap up to elbows, sterile towel to dry, followed by alcohol gel (Group B)
Trial: 28341129
Drug: Hand washing
RxNorm normalized name: ALCOHOL 350 mL in 500 mL EXTRACORPOREAL GEL [75% alcohol free hand washing gel]
DrugBank: Citric acid (DB04272)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hand washing with soap up to elbows, non‐sterile towel to dry, followed by alcohol gel (Group C)
Trial: 24418055
Drug: ABT-384 10
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-384 10 mg once daily
Trial: 24418055
Drug: ABT-384 50
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-384 50 mg once daily
Trial: 29854928
Drug: Donepezil 10
RxNorm normalized name: donepezil 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Donepezil 10 mg once daily
Trial: 22048324
Drug: L-arginine (4.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (4.25 mmol L(‐1))
Trial: 22048324
Drug: L-glutamine (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-glutamine (45 mmol L(‐1))
Trial: 17488518
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m2 d1 and cisplatin 75 mg/m2 d1, q 3 weeks
Trial: 12127641
Drug: Mifepristone 200
RxNorm normalized name: mifepristone 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone 200 mg orally followed by misoprostol 0.8 mg orally or vaginally 36-48 hours later
Trial: 9667273
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg methylphenidate twice daily
Trial: 9667273
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg methylphenidate twice daily
Trial: 9667273
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg methylphenidate twice daily
Trial: 9667273
Drug: methylphenidate treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: methylphenidate treatment
Trial: 8137524
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg cetrorelix
Trial: 8137524
Drug: 2 mg
RxNorm normalized name: iodine 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 mg cetrorelix
Trial: 8137524
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg cetrorelix
Trial: 22891232
Drug: FSV/TPGS preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSV/TPGS preparation coadministered with additional vitamin K
Trial: 22891232
Drug: FSV/TPGS preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FSV/TPGS preparation
Trial: 20543018
Drug: On-call physical
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: On-call physical therapy
Trial: 20543018
Drug: Regular physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular physical therapy (Control)
Trial: 17720303
Drug: Moderate atherosclerosis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate atherosclerosis (no specific treatment mentioned)
Trial: 15925748
Drug: L-NMMA (intra-arterial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (intra-arterial infusion of 4 micromol/min)
Trial: 12885701
Drug: Bread and
RxNorm normalized name: Low protein bread and bread rolls
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bread and cookies rich in beta-glucan (5.9 g/day)
Trial: 12885701
Drug: Orange juice
RxNorm normalized name: Orange juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orange juice containing beta-glucan (5 g/day)
Trial: 1482265
Drug: Angiotensin-converting enzyme
RxNorm normalized name: ACE - Angiotensin-converting enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Angiotensin-converting enzyme inhibitors (CEI)
Trial: 1482265
Drug: Calcium antagonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium antagonists (CA)
Trial: 3912334
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg i.v. indoprofen
Trial: 3912334
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg i.m. morphine hydrochloride
Trial: 31679509
Drug: Intermittent boluses
RxNorm normalized name: phenylbutazone
DrugBank: Phenylbutazone (DB00812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent boluses (1.5 mcg/Kg phenylephrine)
Trial: 31679509
Drug: Fixed on-and-off
RxNorm normalized name: Off! Explore
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed on-and-off infusion (0.75 mcg/Kg/min)
Trial: 31679509
Drug: Variable infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Variable infusion (0.75 mcg/Kg/min)
Trial: 15718305
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m² once every 3 weeks
Trial: 10340423
Drug: Intrathecal baclofen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrathecal baclofen (50 microg bolus injection)
Trial: 31039763
Drug: BM-MSCs treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BM-MSCs treatment
Trial: 26669546
Drug: Immediate implant
RxNorm normalized name: IR-3535
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate implant placement (25 patients)
Trial: 26669546
Drug: Delayed implant
RxNorm normalized name: Drug Implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Delayed implant placement (25 patients)
Trial: 12195603
Drug: Ipratropium bromide
RxNorm normalized name: Ipratropium Bromide
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium bromide 40 micro g four times daily
Trial: 9578047
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg midazolam (MDL) in 2 ml peppermint-flavored fluid
Trial: 10522780
Drug: Controlled-release of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release of subgingivally delivered doxycycline hyclate in a polylactic acid based polymer gel
Trial: 2072698
Drug: Intraluminal radiotherapy
RxNorm normalized name: taurolidine
DrugBank: Taurolidine (DB12473)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraluminal radiotherapy (ILRT) plus concurrent 5-fluorouracil (5-FU) infusion
Trial: 6849205
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg metronidazole intravenously every 6 hours for three doses
Trial: 30730785
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg of folic acid for 16 weeks
Trial: 29573207
Drug: Rolontis 270
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolontis 270 μg/kg
Trial: 29573207
Drug: Rolontis 135
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolontis 135 μg/kg
Trial: 29573207
Drug: Rolontis 45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rolontis 45 μg/kg
Trial: 26853325
Drug: Dexamethasone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone (12 mg/day for 3 weeks followed by tapering)
Trial: 19864114
Drug: First-generation antipsychotic
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotic (perphenazine)
Trial: 19864114
Drug: Second-generation antipsychotic
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Second-generation antipsychotic (quetiapine)
Trial: 11896327
Drug: PEN110 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEN110 treatment (pathogen-inactivated RBCs)
Trial: 11896327
Drug: PEN110 treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEN110 treatment
Trial: 27650139
Drug: Lip training
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lip training with 200 or 400 g of bottled water in the oral vestibule
Trial: 25183507
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of rosemary essential oil for three minutes
Trial: 25183507
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of lavender essential oil for three minutes
Trial: 25183507
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of eucalyptus essential oil for three minutes
Trial: 22613015
Drug: Intervention A
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention A (written information - leaflet describing correct inhalation techniques)
Trial: 22613015
Drug: Intervention B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention B (written information about inhalation techniques plus training by an instructor)
Trial: 16439851
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) treatment (1 or 2 mg/m2/day)
Trial: 11593632
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg of tPA (Group I; n = 26)
Trial: 1376503
Drug: Monoclonal antibody
RxNorm normalized name: Monoclonal antibody
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monoclonal antibody staining of needle core biopsies (MABS)
Trial: 29210808
Drug: Haloperidol (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (1 mg twice daily for 7 days)
Trial: 29210808
Drug: Placebo (twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (twice daily for 7 days)
Trial: 22126416
Drug: IgE-antibody to
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IgE-antibody to Ara h 1, 2, and 3
Trial: 19522751
Drug: Celecoxib (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Celecoxib (400 mg/day for 9 days after bout 1)
Trial: 18630774
Drug: Caffeine benzoate,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Caffeine benzoate, 20 mg/kg IV
Trial: 12122787
Drug: Extracorporeal Shock
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extracorporeal Shock Wave Therapy (ESWT, 2000 pulses, energy flux density ED+ 0.1 mJ/mm2, 3 times in 1 week intervals)
Trial: 10607226
Drug: Consensus interferon
RxNorm normalized name: Interferon Gamma
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Consensus interferon (IFN) treatment
Trial: 10607226
Drug: IFN‐alpha2b treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN‐alpha2b treatment
Trial: 913045
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of adrenaline
Trial: 31018017
Drug: Person‐Centred Experiential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Person‐Centred Experiential Therapy (PCET)
Trial: 28687551
Drug: Nebulized morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine 20 mg every 4 hours
Trial: 28687551
Drug: Nebulized fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Nebulized fentanyl 25 and 100 μg
Trial: 28687551
Drug: Nebulized hydromorphone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized hydromorphone 5 mg
Trial: 28687551
Drug: Nebulized morphine-6-glucuronide
RxNorm normalized name: MENTHOL GLUCURONIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized morphine-6-glucuronide
Trial: 28687551
Drug: Other nebulized
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other nebulized opioids (various doses)
Trial: 25047796
Drug: Intravenous dexketoprofen
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexketoprofen trometamol (50 mg) and intraarticular normal saline (20 mL)
Trial: 25047796
Drug: Intraarticular 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular 0.5 % levobupivacaine (100 mg) and intravenous normal saline (2 mL)
Trial: 25047796
Drug: Intraarticular 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraarticular 0.5 % levobupivacaine (100 mg) and intravenous dexketoprofen trometamol (50 mg)
Trial: 15684155
Drug: Dilute oxytocin
RxNorm normalized name: Oxytocin
DrugBank: Oxytocin (DB00107)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dilute oxytocin infusion (10 IU in 500 mL saline at 125 mL/h)
Trial: 12851521
Drug: Continuous‐combined hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous‐combined hormone replacement therapy (0.625 mg/day conjugated equine estrogen plus 5 mg/day medroxyprogesterone)
Trial: 12851521
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no HRT treatment)
Trial: 6758933
Drug: Tiapamil (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiapamil (intravenous and/or oral)
Trial: 29228473
Drug: Desvenlafaxine (50,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desvenlafaxine (50, 100, and 200 mg)
Trial: 27043082
Drug: Losmapimod (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losmapimod (7.5 mg, twice daily)
Trial: 20557835
Drug: S-etodolac ER
RxNorm normalized name: etodolac Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: S-etodolac ER 300 mg
Trial: 20557835
Drug: etodolac ER
RxNorm normalized name: Etodolac ER
DrugBank: Etodolac (DB00749)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: etodolac ER 600 mg
Trial: 12817528
Drug: Repaglinide with
RxNorm normalized name: Repaglinide
DrugBank: Repaglinide (DB00912)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Repaglinide with strong inhibitors or inducers of CYP3A4
Trial: 2057103
Drug: phytostimolin cream
RxNorm normalized name: thymostimulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: phytostimolin cream and vaginal lavage
Trial: 6337761
Drug: Indenolol (30-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indenolol (30- or 60-mg tablets, twice daily for 14 days)
Trial: 26628249
Drug: Multisystemic Therapy‐Health
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multisystemic Therapy‐Health Care (MST‐HC)
Trial: 22270216
Drug: Prednisone (steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (steroid group) for 15 days starting with 100 mg at surgery, tapered to 12.5 mg.
Trial: 22270216
Drug: Placebo (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (control group) administered in a comparable manner to the steroid group.
Trial: 22270216
Drug: Prednisone (steroid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone (steroid group)
Trial: 17207145
Drug: Future use
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Future use of the Vi vaccine
Trial: 10554747
Drug: Prilocaine plus
RxNorm normalized name: Prilocaine
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Prilocaine plus lidocaine cream (Group A)
Trial: 10554747
Drug: Lidocaine spray
RxNorm normalized name: lidocaine Mucosal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine spray (Group B)
Trial: 1659601
Drug: Immunoblot assay
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunoblot assay using recombinant-baculovirus-expressed glycoprotein G (gG1 or gG2)
Trial: 27884853
Drug: Gyejibongneyong-hwan (GBH)
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gyejibongneyong-hwan (GBH) administered three times per day for two menstrual periods (8 weeks)
Trial: 27884853
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered three times per day for two menstrual periods (8 weeks)
Trial: 15908760
Drug: Cream preparations
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream preparations containing marigold and rosemary extracts
Trial: 15908760
Drug: Sequential treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential treatment (postirritation) once a day for 5 days
Trial: 9667295
Drug: Head-up position
RxNorm normalized name: Head & Shoulders
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Head-up position (after norepinephrine or phenylephrine infusion)
Trial: 7660342
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 200 micrograms aqueous nasal spray administered twice daily for two weeks
Trial: 996687
Drug: Oral oxamniquine
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral oxamniquine at a total dose of 60 mg/kg (given in 4 equal doses morning and evening over 2 days, after food)
Trial: 996687
Drug: Lower doses
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower doses or shorter schedules of treatment
Trial: 996687
Drug: Oral oxamniquine
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral oxamniquine